S<sub>8</sub>-Catalyzed triple cleavage of bromodifluoro compounds for the assembly of N-containing heterocycles
作者:Shuilin Deng、Haohua Chen、Xingxing Ma、Yao Zhou、Kai Yang、Yu Lan、Qiuling Song
DOI:10.1039/c9sc01333d
日期:——
cleavage of three C–X bonds, including two inert C(sp3)–F bonds on bromodifluoroacetamides, while leaving C–C bonds intact. This strategy will undoubtedly further consummate the role of halo difluoro compounds and enrich both fluorine chemistry and pharmaceutical sciences.
PETYUNIN, P. A.;ABDUL, MALEK, CHOUDRI, XIMIYA GETEROTSIKL. SOEDIN., 1982, N 5, 684-686
作者:PETYUNIN, P. A.、ABDUL, MALEK, CHOUDRI
DOI:——
日期:——
INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
申请人:Pardes Biosciences, Inc.
公开号:US20220162194A1
公开(公告)日:2022-05-26
The disclosure provides compounds, such as compounds of Formula II, with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease.
Synthesis of benzimidazole-2-carboxylic acid amides from o-phenylenediamine and oxamic acid esters